beta-resorcylic acid has been researched along with Hyperuricemia in 1 studies
beta-resorcylic acid: RN given refers to parent cpd; structure
Hyperuricemia: Excessive URIC ACID or urate in blood as defined by its solubility in plasma at 37 degrees C; greater than 0.42mmol per liter (7.0mg/dL) in men or 0.36mmol per liter (6.0mg/dL) in women. This condition is caused by overproduction of uric acid or impaired renal clearance. Hyperuricemia can be acquired, drug-induced or genetically determined (LESCH-NYHAN SYNDROME). It is associated with HYPERTENSION and GOUT.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yong, T | 1 |
| Liang, D | 1 |
| Xiao, C | 1 |
| Huang, L | 1 |
| Chen, S | 1 |
| Xie, Y | 1 |
| Gao, X | 1 |
| Wu, Q | 1 |
| Hu, H | 1 |
| Li, X | 1 |
| Liu, Y | 1 |
| Cai, M | 1 |
1 other study available for beta-resorcylic acid and Hyperuricemia
| Article | Year |
|---|---|
Hypouricemic effect of 2,4-dihydroxybenzoic acid methyl ester in hyperuricemic mice through inhibiting XOD and down-regulating URAT1.
Topics: Allopurinol; Animals; Benzbromarone; Esters; Hydroxybenzoates; Hyperuricemia; Kidney; Mice; Uric Aci | 2022 |